» Articles » PMID: 37096658

Danggui Buxue Decoction Alleviates Cyclophosphamide-induced Myelosuppression by Regulating β-hydroxybutyric Acid Metabolism and Suppressing Oxidative Stress

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2023 Apr 25
PMID 37096658
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Danggui Buxue Decoction (DBD) is an effective complementary medicine in alleviating myelosuppression after chemotherapy (MAC). However, its mechanism of action is elusive.

Objective: To illustrate that regulating β-hydroxybutyric acid (β-OHB) metabolism and suppressing oxidative stress could be a potential mechanism of action for DBD in alleviating MAC.

Materials And Methods: After HPLC quantification and dose testing (3, 6 and 10 g/kg, gavage) of DBD, Sprague-Dawley rats were divided into control, cyclophosphamide (CTX) (30 mg/kg CTX for 5 days, intraperitoneal administration) and CTX + DBD groups (6 g/kg DBD for 14 days, gavage). Blood cell counts, thigh bone histological examination, β-OHB levels, oxidative stress indices and HDAC1 activity were tested. The biological function of β-OHB was verified (hBMSC cells were incubated in culture mediums that contained 40 μM CTX and β-OHB in 0, 1, 2.5, 5, 10 mM) and (MAC rat model, 3 g/kg β-OHB for 14 days, gavage).

Results: Rats in the CTX + DBD group showed upregulated blood cell counts (118-243%), β-OHB levels (495 nmol/mL in blood, 122 nmol/mg in marrow supernatant) and downregulated HDAC1 activity (59%), and oxidative stress indices (60-85%). , 5 mM β-OHB improved hBMSC cell migration (123%) and proliferation (131%). , rats treated with 3 g/kg β-OHB showed upregulated blood cell counts (121-182%) and downregulated HDAC1 activity (64%) and oxidative stress indices (65-83%).

Discussion And Conclusions: DBD, a traditional Chinese medicine, alleviates MAC by intervening in β-OHB metabolism and oxidative stress.

Citing Articles

Formation of self-assembly aggregates in traditional Chinese medicine decoctions and their application in cancer treatments.

Fang C, Wang Y, Pan Z RSC Adv. 2025; 15(7):5476-5506.

PMID: 39967882 PMC: 11833604. DOI: 10.1039/d4ra07212j.


Mechanisms of (Fisch.) Bge. var. mongholicus (Bge.) Hsiao (huang qi) and (Oliv.) Diels (dang gui) in Ameliorating Hypoxia and Angiogenesis to Delay Pulmonary Nodule Malignant Transformation.

Guo Y, Yang P, Wu Z, Zhang S, You F Integr Cancer Ther. 2025; 24:15347354241311917.

PMID: 39882753 PMC: 11780663. DOI: 10.1177/15347354241311917.


Danggui Jixueteng decoction for the treatment of myelosuppression after chemotherapy: A combined metabolomics and network pharmacology analysis.

Guo M, Zeng J, Li W, Hu Z, Shen Y Heliyon. 2024; 10(3):e24695.

PMID: 38314262 PMC: 10837499. DOI: 10.1016/j.heliyon.2024.e24695.


Impact of macrophage differentiation on hematopoietic function enhancement by Shenzhu ErKang Syrup.

Li Y, Teng M, Yang H, Li S, Liu X, Zhang J Aging (Albany NY). 2024; 16(1):169-190.

PMID: 38175693 PMC: 10817372. DOI: 10.18632/aging.205358.

References
1.
Shimazu T, Hirschey M, Newman J, He W, Shirakawa K, Le Moan N . Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2012; 339(6116):211-4. PMC: 3735349. DOI: 10.1126/science.1227166. View

2.
Mukaka M . Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2013; 24(3):69-71. PMC: 3576830. View

3.
Samadi M, Gholizadeh-Ghaleh Aziz S, Naderi R . The effect of tropisetron on oxidative stress, SIRT1, FOXO3a, and claudin-1 in the renal tissue of STZ-induced diabetic rats. Cell Stress Chaperones. 2020; 26(1):217-227. PMC: 7736377. DOI: 10.1007/s12192-020-01170-5. View

4.
Wei Q, Frenette P . Niches for Hematopoietic Stem Cells and Their Progeny. Immunity. 2018; 48(4):632-648. PMC: 6103525. DOI: 10.1016/j.immuni.2018.03.024. View

5.
Zhang H, Zhang L, Yang C, Zhang Y, Li J, Zhang X . Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide. Front Pharmacol. 2022; 13:845034. PMC: 9011104. DOI: 10.3389/fphar.2022.845034. View